Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation

Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation

Bibliographic Details
Main Authors: Liu, Jing, Xing, Ligang, Meng, Xue, Yue, Jinbo, Meng, Xiangjiao, Xie, Peng, Li, Xiaolin, Kong, Li, Yu, Jinming
Format: Online
Language:English
Published: Dove Medical Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751907/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751907/

Similar Items